Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

Clinical trial NCT07185815 · RECRUITING

Trial details

NCT number: NCT07185815
Sponsor: Mapi Pharma Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Schizophrenia Bipolar I Disorder Major Depressive Disorder

Start date: 2025-08-01
Primary completion: 2026-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.